PTP4A1 and systemic sclerosis: Since early stages of SSc are characterized by enhanced immune-mediated inflammation, it is also possible that additional cytokines/inflammatory stimuli boost PTP4A1/PTP4A2 expression in early vs. late SSc biopsies.